1 completed, 1 terminated. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Aspen Global Incorporated: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban Danaparoid Sodium, Argatroban - Heparin-induced Thrombocytopenia | Phase 3 | Terminated | Aspen Global Incorporated | 7 | 2019-05-16 | 2022-12-08 |
| A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers. Sodium chloride - Injection Site Reaction | Phase 4 | Completed | Aspen Global Incorporated | 15 | 2016-06-02 | 2019-02-15 |
Sodium Chloride (1) · argatroban (1) · danaparoid (1)
Bosnia and Herzegovina (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · Russia (1) · Serbia (1) · United States (1)